People who have lived with HIV long-term can need up to a dozen pills every day to suppress the virus. Results from a new drug trial raise hope of changing that.
The next-generation syringe is now approved for use in the EU, the U.S., and Canada with the NASHA ® lidocaine range of Restylane products including, Restylane Lyft™ Lidocaine, Restylane Eyelight™ and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results